The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans

CM Hysek, LD Simmler, M Ineichen… - Clinical …, 2011 - Wiley Online Library

Author(s): Linda Simmler

Focus: MDMA

Abstract:

This study assessed the pharmacodynamic and pharmacokinetic effects of the interaction between the selective norepinephrine (NE) transporter inhibitor reboxetine and 3, 4‐methylenedioxymethamphetamine (MDMA,“ecstasy”) in 16 healthy subjects. The study used …